Prognostic value of the C-reactive protein-albumin-lymphocyte index versus traditional inflammatory markers after radical resection of colorectal cancer: a retrospective cohort study

C反应蛋白-白蛋白-淋巴细胞指数与传统炎症标志物在结直肠癌根治术后预后价值的比较:一项回顾性队列研究

阅读:1

Abstract

OBJECTIVE: To compare the prognostic value between the C-reactive protein-albumin-lymphocyte index (CALLY) and traditional inflammatory markers [including the neutrophil-to-lymphocyte ratio (NLR), the lymphocyte-to-monocyte ratio (LMR), and the platelet-to-lymphocyte ratio (PLR)] after radical resection of colorectal cancer (CRC). METHODS: A total of 152 CRC patients who underwent radical resection in Baotou Central Hospital from January 2016 to December 2019 were selected and studied retrospectively. The clinicopathological traits of the patients were collected and analyzed, and their survival outcomes were followed up. The prognostic value of the CALLY index and classical CRC prognostic factors was compared through the concordance index (CI) and the area under the receiver operating characteristic curve (AUC). The COX risk regression model was used for multivariate analysis to evaluate the impact of different indicators on prognosis. RESULTS: The AUC of the CALLY index was 0.789 (95%CI: 0.703-0.875, P < 0.001), which was significantly higher than that of NLR (0.664, 95%CI: 0.574-0.754), LMR (0.655, 95%CI: 0.559-0.751), and PLR (0.647, 95%CI: 0.553-0.740). The 5-year overall survival (OS) rate in the high CALLY group (≥ 1.045) was significantly better than that in the low CALLY group (83.5% vs. 12.9%, P < 0.001). Multivariate analysis showed that the CALLY index (HR = 0.124; 95%CI 0.060-0.255; P < 0.05) was an independent prognostic factor. Moreover, an increased CALLY index was associated with a better prognosis, suggesting this indicator is a protective factor of post-surgical prognosis in CRC patients. CONCLUSION: By integrating inflammation, nutrition, and immune status, the CALLY index performs significantly better than traditional single indicators in postoperative prognostic prediction in CRC patients. It can serve as a reliable tool for postoperative prognostic evaluation of CRC and provide incremental value for clinical risk stratification.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。